Choueiri Choueiri TK TK Xie Xie W W D’amico D’amico AV AV Time to prostate-specific antigen nadir independently predicts overall survival in patients who have metastatic hormone-sensitive prostate cancer treated with androgen-deprivation therapy Time to prostate-specific antigen nadir independently predicts overall survival in patients who have metastatic hormone-sensitive prostate cancer treated with androgen-deprivation therapy Cancer Cancer 2009 2009 115 115 981 981 987 987 supplied-pmid 19152438? This evidence concerns the gene KLK3 and cancer.